Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events

BACKGROUND: The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA) is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and autoantibodies could be involved in the pathogenesis of atherosclerotic disease. It has been suggested that anti-phosphory...

Descripción completa

Detalles Bibliográficos
Autores principales: Ajeganova, Sofia, Andersson, Maria L. E., Frostegård, Johan, Hafström, Ingiäld
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314464/
https://www.ncbi.nlm.nih.gov/pubmed/34311770
http://dx.doi.org/10.1186/s13075-021-02581-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314464/
https://www.ncbi.nlm.nih.gov/pubmed/34311770
http://dx.doi.org/10.1186/s13075-021-02581-0

Ejemplares similares